Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Prelude Therapeutics Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- −8 vs. Q2 2022
- Shares held
- 31.8M
- −913.7K (−2.8%) vs. Q2 2022
- Total value
- $210.3M
- +$39.5M (+23.1%) vs. Q2 2022
- New holders
- 5
- 16 more added
- Sold out
- 13
- 20 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $264.3M |
| Q1 2026 | 55 | $105.2M |
| Q4 2025 | 48 | $82.6M |
| Q3 2025 | 47 | $39.1M |
| Q2 2025 | 50 | $22.0M |
| Q1 2025 | 59 | $23.3M |
| Q4 2024 | 62 | $41.0M |
| Q3 2024 | 70 | $74.0M |
| Q2 2024 | 61 | $129.2M |
| Q1 2024 | 58 | $162.1M |
| Q4 2023 | 56 | $148.3M |
| Q3 2023 | 60 | $113.1M |
| Q2 2023 | 55 | $176.2M |
| Q1 2023 | 55 | $179.6M |
| Q4 2022 | 60 | $188.3M |
| Q3 2022 | 53 | $210.3M |
| Q2 2022 | 62 | $170.9M |
| Q1 2022 | 68 | $235.4M |
| Q4 2021 | 75 | $437.6M |
| Q3 2021 | 61 | $1.12B |
| Q2 2021 | 57 | $986.6M |
| Q1 2021 | 60 | $1.41B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 10,123,824 | $66.9M | 0.44% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 10,039,691 | $66.4M | 1.32% | 00.0% | Unchanged |
| FMR LLC | 4,638,547 | $30.7M | 0.00% | +335,578+7.8% | Added |
| UBS Asset Management Americas Inc | 2,402,595 | $15.9M | 0.01% | −17,932−0.7% | Reduced |
| Vanguard Group Inc | 899,045 | $5.94M | 0.00% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 583,333 | $3.86M | 0.10% | 00.0% | Unchanged |
| Massachusetts Financial Services Co | 513,293 | $3.39M | 0.00% | +34,768+7.3% | Added |
| BlackRock Inc. | 459,134 | $3.03M | 0.00% | −70,301−13.3% | Reduced |
| Price T Rowe Associates Inc | 313,165 | $2.07M | 0.00% | +5,812+1.9% | Added |
| Morgan Stanley | 177,788 | $1.18M | 0.00% | −303,000−63.0% | Reduced |
| Bank of America Corp | 167,478 | $1.11M | 0.00% | +33,983+25.5% | Added |
| Geode Capital Management, LLC | 153,091 | $1.01M | 0.00% | +17,450+12.9% | Added |
| Renaissance Technologies LLC | 143,400 | $948.0K | 0.00% | −17,086−10.6% | Reduced |
| Candriam Luxembourg S.C.A. | 125,619 | $830.0K | 0.01% | +125,619 | New |
| Two Sigma Advisers, LP | 109,533 | $724.0K | 0.00% | −126,167−53.5% | Reduced |
| State of Wisconsin Investment Board | 109,100 | $721.0K | 0.00% | −18,100−14.2% | Reduced |
| Two Sigma Investments, LP | 105,601 | $698.0K | 0.00% | −118,235−52.8% | Reduced |
| Caxton Associates LP | 85,992 | $568.0K | 0.10% | +2,125+2.5% | Added |
| D. E. Shaw & Co., Inc. | 78,881 | $521.0K | 0.00% | −36,986−31.9% | Reduced |
| New York Life Investment Management LLC | 73,393 | $485.0K | 0.01% | +5,808+8.6% | Added |
| Millennium Management LLC | 60,426 | $399.0K | 0.00% | −30,511−33.6% | Reduced |
| Charles Schwab Investment Management Inc | 54,052 | $358.0K | 0.00% | −9,148−14.5% | Reduced |
| Gsa Capital Partners LLP | 54,173 | $358.0K | 0.05% | +17,547+47.9% | Added |
| State Street Corp | 43,889 | $290.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 36,949 | $244.0K | 0.01% | −10,000−21.3% | Reduced |
| Manufacturers Life Insurance Company, The | 34,267 | $223.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 29,179 | $193.0K | 0.00% | −100.0% | Reduced |
| TD Asset Management Inc | 28,440 | $185.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 24,180 | $160.0K | 0.06% | +175+0.7% | Added |
| Goldman Sachs Group Inc | 21,735 | $144.0K | 0.00% | −22,560−50.9% | Reduced |
| Northern Trust Corp | 21,167 | $140.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 15,734 | $104.0K | 0.00% | −93,889−85.6% | Reduced |
| Commonwealth Equity Services, LLC | 15,867 | $104.0K | 0.00% | −750−4.5% | Reduced |
| Dimensional Fund Advisors LP | 14,616 | $97.0K | 0.00% | +14,616 | New |
| Susquehanna International Group, LLP | 13,591 | $90.0K | 0.00% | −15,837−53.8% | Reduced |
| PDT Partners, LLC | 12,641 | $84.0K | 0.01% | −31,090−71.1% | Reduced |
| Citigroup Inc | 8,532 | $56.0K | 0.00% | +7,691+914.5% | Added |
| Denali Advisors LLC | 8,200 | $54.0K | 0.03% | +8,200 | New |
| Barclays PLC | 5,168 | $34.0K | 0.00% | +1,108+27.3% | Added |
| Royal Bank of Canada | 4,200 | $28.0K | 0.00% | +1,699+67.9% | Added |
| Nisa Investment Advisors, LLC | 4,000 | $27.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,451 | $16.0K | 0.00% | +418+20.6% | Added |
| Tower Research Capital LLC (TRC) | 1,254 | $9.00K | 0.00% | −2,770−68.8% | Reduced |
| Quantbot Technologies LP | 1,400 | $9.00K | 0.00% | −1,400−50.0% | Reduced |
| Federated Hermes, Inc. | 1,407 | $9.00K | 0.00% | +1,141+428.9% | Added |
| Advisor Group Holdings, Inc. | 500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 470 | $3.00K | 0.00% | +470 | New |
| China Universal Asset Management Co., Ltd. | 448 | $3.00K | 0.00% | +448 | New |
| Wells Fargo & Company | 371 | $2.00K | 0.00% | +184+98.4% | Added |
| Daiwa Securities Group Inc. | 104 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 68 | $0 | 0.00% | −2,638−97.5% | Reduced |
| Capital Advisors, Ltd. LLC | 33 | $0 | 0.00% | +22+200.0% | Added |
| HighMark Wealth Management LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −368,959−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −45,716−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −39,938−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −23,640−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,618−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −16,940−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,586−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −8,080−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Brewin Dolphin Wealth Management Ltd | – | – | – | – | Not filed |